Jasper Therapeutics, Inc. (NASDAQ:JSPR) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Herb Cross Other companies: Apexigen Inc. (Director · Jul 29, 2022 – Aug 23, 2023 · Past); Atreca Inc (Chief Financial Officer · Jun 19, 2019 – Aug 2, 2023 · Past); Armo Biosciences Inc. (Chief Financial Officer · Jan 25, 2018 – Jun 22, 2018 · Past); Humanigen Inc (Chief Financial Officer · Oct 22, 2013 – Nov 9, 2015 · Past); Affymax Inc (Chief Financial Officer · Nov 15, 2010 – Jan 30, 2013 · Past); Facet Biotech Corp (VP of Finance · Dec 9, 2008 – Apr 21, 2010 · Past); PDL BioPharma Inc (Corp Controller/Prin Acctg Off · Jun 20, 2007 – Sep 15, 2008 · Past); Neoforma Inc (VP of Finance · Dec 31, 2005 – Dec 31, 2005 · Past) | Chief Financial Officer · Since at least Sep 22, 2023 |
| Thomas Wiggans Other companies: Pacira BioSciences, Inc. (Director · Since at least Jun 9, 2026); Annexon, Inc. (Director · Since at least Jul 23, 2020); Pardes Biosciences Inc (Chief Executive Officer, Director · Mar 1, 2022 – Aug 31, 2023 · Past); Forma Therapeutics Holdings Inc (Director · Sep 7, 2020 – Oct 14, 2022 · Past); Somaxon Pharmaceuticals Inc (Director · Jun 11, 2008 – Jul 2, 2012 · Past); Sangamo Therapeutics, Inc. (Director · Jun 4, 2008 – Jun 1, 2011 · Past); Onyx Pharmaceuticals Inc (Director · Aug 29, 2007 – Oct 1, 2013 · Past) | Chairman of the Board · Since at least Nov 1, 2023 |
| Lawrence Klein Other companies: Jade Biosciences, Inc. (Chief Executive Officer, Oruka Therapeutics · Since at least Apr 28, 2025); Oruka Therapeutics, Inc. (Chief Executive Officer, Director · Since at least Aug 29, 2024); Dyne Therapeutics, Inc. (Director · Jul 31, 2020 – Jul 5, 2022 · Past); CRISPR Therapeutics AG (CBO & COO · Jan 2, 2019 – Aug 16, 2022 · Past) | Director · Sep 24, 2021 – Jun 7, 2023 · Past |
| Howard I Hoffen Other companies: EnerSys (Director · Since at least Dec 12, 2006); Jones Energy Inc (Director · Jul 23, 2013 – May 27, 2016 · Past); Union Drilling Inc (Director · Nov 27, 2007 – Nov 5, 2012 · Past) | Director · Nov 19, 2019 – Jan 3, 2020 · Past |
| William Lis Other companies: Zai Lab Ltd. (Board Member · Since at least Jan 1, 2021); Eidos Therapeutics Inc (Director · Dec 4, 2018 – Jan 26, 2021 · Past); Portola Pharmaceuticals Inc (Chief Executive Officer, Director · May 21, 2013 – Jul 28, 2018 · Past) | Director · Sep 24, 2021 – Oct 13, 2023 · Past |
| Glenn Reicin Other companies: Harmony Biosciences Holdings, Inc. (Chief Financial Officer · Since at least Apr 14, 2026); Sigilon Therapeutics Inc (CHIEF FINANCIAL OFFICER · Dec 3, 2020 – Feb 11, 2021 · Past) | Director · Nov 19, 2019 – Nov 19, 2019 · Past |
| Kurt von Emster Other companies: Vera Therapeutics, Inc. (Director · May 13, 2021 – May 17, 2021 · Past); Vaxcyte, Inc. (Director · Jun 11, 2020 – Jun 2, 2021 · Past) | Board Member · Since at least Sep 24, 2021 |
| Scott Brun Other companies: Forte Biosciences, Inc. (Director · Since at least Nov 10, 2022); Cabaletta Bio, Inc. (Independent Director, formerly at AbbVie · Since at least Jun 24, 2021) | Director · Since at least Jun 20, 2023 |
| Svetlana Lucas Other companies: Scribe Therapeutics Inc. (Chief Business Officer · Since at least Mar 13, 2026); aTyr Pharma, Inc. (Director · Since at least Jun 28, 2019) | Board Member · Since at least Jun 18, 2024 |
| Greg Keenan Other companies: Aurinia Pharmaceuticals Inc (SVP, Chief Medical Officer · Since at least Nov 7, 2024) | Chief Medical Officer · Since at least Jul 16, 2026 |
| Abby Kennedy | Vice President, Clinical Operations · Since at least Nov 4, 2026 |
| Greg Keenan | Chief Medical Officer · Since at least Oct 15, 2026 |
| Helen Fu | Vice President, Corporate Portfolio and Project Management · Since at least Nov 5, 2026 |
| Jeetinder Singh Mahal | CEO and President, Director · Since at least Sep 24, 2021 |
| Jeet Mahal | Chief Executive Officer · Since at least Sep 15, 2026 |
| Judith Shizuru | Director · Since at least Sep 24, 2021 |
| Kenneth F Clifford | Chief Financial Officer · Nov 19, 2019 – Jan 3, 2020 · Past |
| Kevin N Heller | See Remarks · Sep 24, 2021 – Mar 21, 2022 · Past |
| Lisa Pitt | Senior Vice President, Regulatory Affairs · Since at least Sep 15, 2026 |
| Mark Camarena | Vice President, Information Technology and Facilities · Since at least Nov 5, 2026 |
| Matt Ford | Senior Vice President, Human Resources · Since at least Nov 4, 2026 |
| Matthew Ros | Chief Operating Officer · Since at least Jul 16, 2026 |
| Patrick Crutcher | Board Member · Since at least Jul 16, 2026 |
| Rick Ruiz | Vice President, Finance · Since at least Nov 4, 2026 |
| Ron Martell | President, CEO and Director, Director · Since at least Oct 12, 2023 |
| Shiguang Liu | Vice President, Clinical Development · Since at least Sep 15, 2026 |
| Vishal Kapoor | Director · Since at least Jan 6, 2020 |
| Wenru Song | Executive Vice President and Head of R&D · Since at least Jul 16, 2026 |